Form 4: Capital Bancorp Inc. Director Fred Joseph Lewis Reports Transactions in Company Stock
SEC Filing
Director Fred Joseph Lewis reports acquisition of restricted stock units and stock options in Capital Bancorp Inc.
Summary
- Fred Joseph Lewis, a director of Capital Bancorp Inc., filed a Form 4 detailing changes in beneficial ownership.
- The report indicates the acquisition of 1,081 restricted stock units on March 3, 2025, which will vest on March 3, 2026.
- Lewis also acquired 4,000 stock options on March 3, 2025, exercisable from March 3, 2026, to March 3, 2030, at a price of $30.51.
- The report also details existing holdings of common stock, including 27,560 shares held directly and 16,672 shares held indirectly through Dominion Insurance Inc.
- Lewis also holds various stock options granted in previous years with different exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of stock options and restricted stock units could be interpreted as a positive sign, but it's a routine occurrence.
Positives
- The acquisition of restricted stock units and stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Stakeholder Impact
- The reported transactions may influence investor perception of the company's stock.
Key Dates
| Date | Description |
|---|---|
| 12/31/2021 | Date of grant for 3,750 stock options with an exercise price of $13.89 and an expiration date of 12/31/2025. |
| 12/31/2022 | Date of grant for 2,250 stock options with an exercise price of $26.41 and an expiration date of 12/31/2026. |
| 01/01/2024 | Date of grant for 3,485 stock options with an exercise price of $23.54 and an expiration date of 01/01/2028. |
| 01/01/2025 | Date of grant for 3,400 stock options with an exercise price of $24.20 and an expiration date of 01/01/2029. |
| 03/03/2025 | Date of transaction for the acquisition of 1,081 restricted stock units and 4,000 stock options. |
| 03/03/2026 | Vesting date for the 1,081 restricted stock units. |
| 03/03/2026 | Start of exercisable period for the 4,000 stock options acquired on 03/03/2025. |
| 03/03/2030 | Expiration date for the 4,000 stock options acquired on 03/03/2025. |
| 03/04/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.